Synced daily from ClinicalTrials.gov via AACT. Last sync: .
14 hexaminolevulinate clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 8 indications (including Bladder Cancer & Cervical Dysplasia) and 5,760 total planned enrollment. 3 Phase 3 hexaminolevulinate trials and 1 Phase 2, 2 Phase 4 are listed. 2 hexaminolevulinate clinical trials are actively recruiting at 21 U.S. sites across 15 states. Most recent activity: NCT05962541 (Dec 2031).
Where to Participate: All hexaminolevulinate Trial Sites in the U.S. (21 sites across 15 states)
Every actively recruiting hexaminolevulinatetrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
CUT-lessVesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female Volunteers
NCT00785694withdrawnRecurrence of Bladder Cancer After Transurethral Resection With Hexvix
NCT01344902terminatedAn Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon
All hexaminolevulinate trials (14)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female Volunteers
How many hexaminolevulinate clinical trials are there?
14 hexaminolevulinate clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 9 are marked completed.
Are hexaminolevulinate clinical trials recruiting in 2026?
Yes — 2 hexaminolevulinate trials are actively recruiting in 2026, with 21 U.S. sites across 15 states. See the recruiting trials and the per-state site list further down this page.
What conditions is hexaminolevulinate being studied for?
hexaminolevulinate is being studied for Bladder Cancer, Cervical Dysplasia, Cervical Intraepithelial Neoplasia, Colon Cancer, Colorectal Cancer and 5 more. The trials are grouped by indication on this page.
What phase is hexaminolevulinate in?
hexaminolevulinate clinical trials span 2 Phase 4, 3 Phase 3, 1 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors hexaminolevulinate clinical trials?
The lead sponsor across the most hexaminolevulinate trials is Photocure, with 4 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming hexaminolevulinateas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.